We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+1.61%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$71.7B
AUM Growth
+$2.34B
Cap. Flow
+$1.49B
Cap. Flow %
2.08%
Top 10 Hldgs %
21.97%
Holding
3,809
New
183
Increased
1,708
Reduced
1,572
Closed
206

Sector Composition

Rank Sector Weight
1 Technology 10.59%
2 Financials 9.51%
3 Healthcare 8.04%
4 Industrials 6.62%
5 Communication Services 5.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WSG
3451
DELISTED
Wanda Sports Group Company Limited American Depositary Shares
WSG
$43K ﹤0.01%
+10,700
New +$48.2K
MMAT
3452
DELISTED
Meta Materials Inc. Common Stock
MMAT
$41K ﹤0.01%
175
+50
+40% +$13.2K
ANIX icon
3453
Anixa Biosciences
ANIX
$114M
$40K ﹤0.01%
10,040
ADAP
3454
DELISTED
Adaptimmune Therapeutics
ADAP
$39K ﹤0.01%
25,865
+3,730
+17% +$8.72K
DAN icon
3455
CALL
Dana Inc
DAN
$3.2B
$39K ﹤0.01%
+31,300
New +$486K
GSM icon
3456
FerroAtlántica
GSM
$867M
$39K ﹤0.01%
34,547
-8,317
-19% -$11.7K
NEM icon
3457
CALL
Newmont
NEM
$122B
$39K ﹤0.01%
72,200
+18,600
+35% +$723K
JOB icon
3458
GEE Group
JOB
$22.4M
$38K ﹤0.01%
50,853
BLCM
3459
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$38K ﹤0.01%
3,618
+510
+16% +$6.67K
LMRK
3460
CALL
DELISTED
Landmark Infrastructure Partners LP Common Units
LMRK
$38K ﹤0.01%
39,800
+21,600
+119% +$356K
INO icon
3461
Inovio Pharmaceuticals
INO
$72.3M
$37K ﹤0.01%
1,507
+209
+16% +$6.36K
T icon
3462
CALL
AT&T
T
$163B
$37K ﹤0.01%
+16,682
New +$442K
ABBV icon
3463
CALL
AbbVie
ABBV
$434B
$36K ﹤0.01%
13,300
-100
-0.7% -$6.86K
DIN icon
3464
CALL
Dine Brands
DIN
$432M
$36K ﹤0.01%
14,700
-600
-4% -$49.1K
REFR icon
3465
Research Frontiers
REFR
$17.2M
$35K ﹤0.01%
11,000
LLEX
3466
DELISTED
Lilis Energy, Inc. Common Stock
LLEX
$35K ﹤0.01%
105,000
+5,000
+5% +$1.93K
DHF
3467
BNY Mellon High Yield Strategies Fund
DHF
$173M
$34K ﹤0.01%
11,088
MPWR icon
3468
CALL
Monolithic Power Systems
MPWR
$68.1B
$34K ﹤0.01%
+17,800
New +$2.66M
FRO icon
3469
CALL
Frontline
FRO
$8.64B
$33K ﹤0.01%
39,000
+300
+0.8% +$2.42K
V icon
3470
CALL
Visa
V
$675B
$33K ﹤0.01%
21,300
-300
-1% -$53.4K
STON
3471
DELISTED
StoneMor Inc.
STON
$33K ﹤0.01%
29,343
-975
-3% -$1.49K
STNE icon
3472
CALL
StoneCo
STNE
$2.55B
$32K ﹤0.01%
+29,500
New +$984K
AMRN
3473
CALL
Amarin Corp
AMRN
$301M
$31K ﹤0.01%
730
-520
-42% -$182K
DHY
3474
Credit Suisse High Yield Credit Fund
DHY
$240M
$31K ﹤0.01%
12,285
-4,000
-25% -$10.1K
OMER icon
3475
CALL
Omeros
OMER
$956M
$31K ﹤0.01%
+51,400
New +$882K

Similar funds

Raymond James & Associates's Q3 2019 Portfolio in Review

As of Q3 2019, Raymond James & Associates held 3,809 positions worth $71.7B, up 3.4% from $69.4B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Raymond James & Associates's Q3 2019 filing shows 183 new, 1,708 increased, 1,572 reduced and 206 closed positions. Its largest new stake was Change Healthcare Inc. Common Stock: 949,970 shares worth $11.5M. The largest sale was Microchip Technology, an estimated $155M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q3 2019 buy was Change Healthcare Inc. Common Stock: 949,970 shares worth $11.5M.
  • Raymond James & Associates added most to Comcast in Q3 2019, an estimated $203M increase.
  • Raymond James & Associates's biggest Q3 2019 reduction was Microchip Technology, cutting an estimated $155M.
  • Raymond James & Associates fully exited Anadarko Petroleum in Q3 2019, selling an estimated $89.3M.
  • Raymond James & Associates's ten largest holdings make up 22% of its $71.7B portfolio in Q3 2019.
  • Raymond James & Associates opened 183 new positions and closed 206 in Q3 2019.
  • Raymond James & Associates's portfolio value rose 3.4% quarter-over-quarter to $71.7B.

Based on Raymond James & Associates's 13F filing for Q3 2019, filed 7 Nov 2019.